Commonwealth Equity Services’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Commonwealth Equity Services’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-64,503	Closed	-$1.09M	–	2263
2014 Q4	$1.09M	Sell	64,503 -1,050	-2%	-$14.8K	0.01%	857
2014 Q3	$781K	Sell	65,553 -2,556	-4%	-$17.5K	0.01%	987
2014 Q2	$384K	Sell	68,109 -5,165	-7%	-$23.8K	﹤0.01%	1391
2014 Q1	$269K	Buy	73,274 +1,000	+1%	+$3.81K	﹤0.01%	1562
2013 Q4	$243K	Buy	72,274 +3,489	+5%	+$14.4K	﹤0.01%	1593
2013 Q3	$291K	Buy	68,785 +942	+1%	+$4.46K	﹤0.01%	1394
2013 Q2	$312K	Buy	+67,843	New	+$233K	0.01%	1279

Commonwealth Equity Services's AVNR Position: Q1 2015 in Review

Commonwealth Equity Services sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 64,503 shares — an estimated $1.09M sold.

Commonwealth Equity Services first reported a position in AVNR in Q2 2013 and held it in 7 quarters. The position peaked at $1.09M in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

Commonwealth Equity Services reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
Commonwealth Equity Services sold 64,503 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $1.09M.
Commonwealth Equity Services first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q2 2013 and held it in 7 quarters.
Commonwealth Equity Services's AVANIR PHARMACEUTICALS, INC CL A position peaked at $1.09M in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on Commonwealth Equity Services's 13F filing for Q1 2015, filed 28 Apr 2015.